Latest News for: cd3
Edit
Exhibits Submission for Asset-Backed Securities Offerings (Form ABS-EE) (CD 2017-CD3 Mortgage Trust)
Public Technologies 21 Jan 2026
) UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington D.C. 20549 ... 333-207132-10 ... CD 2017-CD3 Mortgage Trust ... CD 2017-CD3 Mortgage Trust published this content on January 21, 2026, and is solely responsible for the information contained herein.
Edit
Asset-Backed Issuer Distribution Report (Form 10-D) (CD 2017-CD3 Mortgage Trust)
Public Technologies 21 Jan 2026
). Distribution Date.. 01/12/26. CD 2017-CD3 Mortgage Trust. Determination Date.. 01/06/26 ... 02/12/26 ... Series 2017-CD3 ... Role ... CD 2017-CD3 Mortgage Trust published this content on January 21, 2026, and is solely responsible for the information contained herein.
Edit
Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T ...
Nasdaq Globe Newswire 13 Nov 2025
Edit
Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology (Form 6-K) (Adagene Inc)
Public Technologies 13 Nov 2025
Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology ... CD3 T cell engagers against unique tumor associated antigens.
Edit
Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell Engager (Form 8-K) (Abpro Holdings Inc)
Public Technologies 04 Nov 2025
Edit
Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025
Nasdaq Globe Newswire 03 Nov 2025
MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics ...
Edit
The Berkshire Eagle
27 Oct 2025
Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025
The Berkshire Eagle
27 Oct 2025
SHANGHAI and HONG KONG, Oct.
- 1
